ATC code M03

ATC code M03 Muscle relaxants is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup M03 is part of the anatomical group M Musculo-skeletal system.[4]

ATC codes
M Musculo-skeletal system
M01 Anti-inflammatory and antirheumatic products
M02 Topical products for joint and muscular pain
M03 Muscle relaxants
M04 Antigout preparations
M05 Drugs for treatment of bone diseases
M09 Other drugs for disorders of the musculo-skeletal system

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM03.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

M03A Muscle relaxants, peripherally acting agents

M03AA Curare alkaloids

M03AA01 Alcuronium
M03AA02 Tubocurarine
M03AA04 Dimethyltubocurarine

M03AB Choline derivatives

M03AB01 Suxamethonium

M03AC Other quaternary ammonium compounds

M03AC01 Pancuronium
M03AC02 Gallamine
M03AC03 Vecuronium
M03AC04 Atracurium
M03AC05 Hexafluronium
M03AC06 Pipecuronium bromide
M03AC07 Doxacurium chloride
M03AC08 Fazadinium bromide
M03AC09 Rocuronium bromide
M03AC10 Mivacurium chloride
M03AC11 Cisatracurium

M03AX Other muscle relaxants, peripherally acting agents

M03AX01 Botulinum toxin

M03B Muscle relaxants, centrally acting agents

M03BA Carbamic acid esters

M03BA01 Phenprobamate
M03BA02 Carisoprodol
M03BA03 Methocarbamol
M03BA04 Styramate
M03BA05 Febarbamate
M03BA51 Phenprobamate, combinations excluding psycholeptics
M03BA52 Carisoprodol, combinations excluding psycholeptics
M03BA53 Methocarbamol, combinations excluding psycholeptics
M03BA71 Phenprobamate, combinations with psycholeptics
M03BA72 Carisoprodol, combinations with psycholeptics
M03BA73 Methocarbamol, combinations with psycholeptics
QM03BA99 Combinations

M03BB Oxazol, thiazine, and triazine derivatives

M03BB02 Chlormezanone
M03BB03 Chlorzoxazone
M03BB52 Chlormezanone, combinations excluding psycholeptics
M03BB53 Chlorzoxazone, combinations excluding psycholeptics
M03BB72 Chlormezanone, combinations with psycholeptics
M03BB73 Chlorzoxazone, combinations with psycholeptics

M03BC Ethers, chemically close to antihistamines

M03BC01 Orphenadrine (citrate)
M03BC51 Orphenadrine, combinations

M03BX Other centrally acting agents

M03BX01 Baclofen
M03BX02 Tizanidine
M03BX03 Pridinol
M03BX04 Tolperisone
M03BX05 Thiocolchicoside
M03BX06 Mephenesin
M03BX07 Tetrazepam
M03BX08 Cyclobenzaprine
M03BX09 Eperisone
M03BX30 Phenyramidol
M03BX55 Thiocolchicoside, combinations
QM03BX90 Guaifenesin

M03C Muscle relaxants, directly acting agents

M03CA Dantrolene and derivatives

M03CA01 Dantrolene

References

  1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. "ATC/DDD Index 2022: code M03". WHO Collaborating Centre for Drug Statistics Methodology.
  5. "ATCvet Index 2022: code QM03". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.